Navigation Links
Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference
Date:6/11/2008

Quark will lead a lecture and present a poster on proprietary siRNA

targeting and delivery approaches

FREMONT, Calif., June 11 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced it will participate in the Cambridge Healthcare Institute's 9th Annual Beyond Genome Conference on June 8-11, 2008 at The Fairmont Hotel, San Francisco, CA.

Elena Feinstein, M.D., Ph.D., Chief Scientific Officer of Quark Pharmaceuticals will be presenting a lecture, "Temporary Inhibition of p53 of siRNA for Prevention of Acute Renal Failure: From Concept to Clinical Trials," at 1:50 PM (PT) on June 11, 2008.

Dr. Feinstein's lecture will discuss AKIi-5 and Quark's proprietary concept of temporarily inhibiting p53 as a systemic therapy to prevent the development of acute kidney injury (AKI) in response to ischemia-reperfusion stress. Following a successful preclinical program focused on safety, AKIi-5 is currently in Phase I clinical trials and represents the first ever systemic dosing of an siRNA in humans.

Dr. Swetlana Boldin-Adamsky, Project Director of Quark, will give a poster presentation, "Non-invasive Aerosol siRNA Delivery for the Treatment of Lung Tumors." The poster will discuss direct delivery of siRNA to the respiratory system by inhalation, a potential delivery method for various disorders, including lung cancer. Remarkably, the anti-cancer siRNA target utilized in these studies was discovered using Quark's proprietary BiFAR functional gene discovery platform. Targeting this gene for cancer treatment is covered by Quark's intellectual property.

Dr. Feinstein stated, "We are excited to participate in this year's Beyond Genome conference. We have successfully administered the first siRNA drug candidate systemically in humans with the initiation of our AKIi-5 Phase I clinical trial. This acc
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
2. The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia
3. Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors
4. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
5. Amira Pharmaceuticals Hires Industry Veteran for CFO Position
6. Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter
7. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
8. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
9. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
10. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
11. Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015  Twelve patients today are preparing to ... transplant at California Pacific Medical Center (CPMC), a Sutter ... procedure will be the largest single-center kidney paired donation ... conducted in the 44-year history of the CPMC Transplant ... with an altruistic donor who did not have a ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Bi-Biomics ... Histology’s paraffin and stain additive. The improvement in ... the binary features present in all daughter cells. ... protocol, chromatin packaging was analyzed at 1000-1600x using ... that chromatin patterning in all daughter cells displayed ...
(Date:3/5/2015)... 2015  In response to the incorrect assertions by ... on February 12, 2015. Impeto Medical SAS ... health and their SUDOSCAN® devices have been proven to ... prefers to have the courts decide this dispute rather ... 40 articles written by Key Opinion Leaders, published by ...
(Date:3/4/2015)... 2015 In an article published and posted ... Health Security review the clinical aspects of diseases caused ... bioweapons. The article, "Clinical Management of Potential Bioterrorism-Related Conditions," ... of the New England Journal of Medicine . ... , and Tom Inglesby—review the clinical management of conditions ...
Breaking Biology Technology:Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 2Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 3Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 4Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2Latest Clinical Information On Bioterrorism Threats 2
... In its second acquisition of the past two months, ... Bay operations of Bedrock Managed Services & Consulting. , ... of information technology services, to establish a physical presence ... will maintain Bedrock's Green Bay office and retain personnel ...
... Aruna Biomedical , a Georgia-based maker of neural stem ... can raise sufficient amounts of angel capital, a company executive ... of Georgia in Athens in 2003, has received funding ... Investment Partners , a Madison-based angel investment network, but it ...
... LLC has received construction and operating permits from the ... million gallon fuel production facility in Cashton. , ,The facility ... owned subsidiary of BEST BioDiesel, a Madison-based fuel technology company. ... the Cashton Green Energy Park, the facility will be completed ...
Cached Biology Technology:Wisconsin tries to woo another stem cell company 2Wisconsin tries to woo another stem cell company 3
(Date:2/18/2015)... SUNNYVALE, Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Conference, Boston, MA Tuesday, March 3, ... Institutional Investors Conference, Orlando, FL Wednesday, ... Accessing Live Webcasts To access the live webcasts for these ...
(Date:2/11/2015)... 11, 2015 According ... Control Market by Product (Cards and Readers, Biometrics, Controllers, ... Government, Industrial, Healthcare, Education) and By Geography - Global Forecast and ... the Access Control Market is expected to ... a CAGR of 10.6% between 2014 and ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting ... company and has launched a new marketing campaign to ... Organization (CLO).  The new campaign focuses on First ... protocol and shipments. The first headline in ... aligns Marken,s priorities with its client,s priorities. Marken recognizes ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... release is available in German . Chicago/Leipzig. ... rapid change. Based on models, scientists can now show that ... for epidemics. Large areas of Canada are apparently approaching this ... climate change. As a result both the area burnt down ...
... and intestinal tract infections, and, like other viruses, must ... to produce proteins and their own viral spawn. Now ... Chinese and Australian universities has found a way to ... the viruses in the laboratory environment, before they come ...
... - A group of scientists from United Kingdom (UK), China ... of peregrine and saker falcons genomes at the 2nd International ... is a part of Falcon Genome Project, launched and funded ... January. The results will enable biologists to better study the ...
Cached Biology News:Rapid rise in wildfires in large parts of Canada? 2Rapid rise in wildfires in large parts of Canada? 3Plasma treatment zaps viruses before they can attack cells 2Genomic sequences of 2 iconic falconry birds - Peregrine and Saker Falcons- successfully decoded 2
... Engine Opticon 2 real-time PCR detection system ... fluorescence excitation (470-505 nm) and two photomultiplier ... nm). The Opticon 2 system is built ... includes a thermal gradient feature. This item ...
... apparatus is used to screen blots of mini ... can screen up to 40 different antibodies or ... strips. The apparatus includes a base plate, 2 ... two 8 x 7 cm membranes, and gaskets ...
... Multicolor capability allows detection of SYBR ... channel, and a range of fluorophores in ... VIC, and TAMRA for a multitude ... discrimination. DNA Engine thermal cycler offers precision ...
Fingerprinting II database sharing tools is an optional module for the Fingerprinting II Basic software package that enables peer-to-peer data exchange over the internet and provides external databas...
Biology Products: